Investors

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Jan 22, 2008 goldstein joseph l Director Automatic Sell 5,000 25.00
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Oct 5, 2010 goldstein joseph l Director Automatic Sell 3,152 28.40
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
Jan 27, 2011 goldstein joseph l Director Automatic Sell 5,401 34.67
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Oct 14, 2011 goldstein joseph l Director Automatic Sell 10,000 65.00
Feb 10, 2011 goldstein joseph l Director Automatic Sell 2,239 35.27
Feb 11, 2011 goldstein joseph l Director Automatic Sell 2,761 36.66
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Jul 1, 2011 goldstein joseph l Director Automatic Sell 10,000 55.91 - 56.40
Mar 9, 2011 goldstein joseph l Director Automatic Sell 3,495 39.35
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Dec 17, 2010 goldstein joseph l Director Automatic Sell 5,281 32.00
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Showing 161-180 of 839 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)